Management of Malignant Pleural Effusions
- 7 November 2012
- book chapter
- Published by Springer Science and Business Media LLC
Abstract
The development of pleural effusions is a common occurrence in patients with neoplastic disease. In one postmortem study, 15 % of patients who died with malignancies were found to have malignant pleural effusions, and the annual incidence of malignant pleural effusions (MPE) in the United States is estimated to be >150,000 cases. The presence of a MPE often portends a poor prognosis; the mean survival after the diagnosis of a MPE ranges from 3 to 12 months, depending on the underlying tumor (lung cancer is generally associated with the shortest average survival time). Patients with MPE often have symptoms that impair their quality of life, such as dyspnea, orthopnea, cough, and chest discomfort, some or all of which can be improved with palliative therapeutic measures.Keywords
This publication has 44 references indexed in Scilit:
- Management of the Patient with a Malignant Pleural EffusionSeminars in Respiratory and Critical Care Medicine, 2010
- Management of Pleural Effusion in the Cancer PatientSeminars in Respiratory and Critical Care Medicine, 2010
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010Thorax, 2010
- Diagnosis and Treatment of Malignant Pleural EffusionAmerican Journal of Clinical Oncology, 2010
- Acute inflammatory response secondary to intrapleural administration of two types of talcEuropean Respiratory Journal, 2009
- Diagnosis and management of malignant pleural effusionsRespirology, 2007
- Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesisEuropean Respiratory Journal, 2007
- The evidence on the effectiveness of management for malignant pleural effusion: a systematic reviewEuropean Journal of Cardio-Thoracic Surgery, 2006
- Rapid Pleurodesis for Malignant Pleural EffusionsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003
- Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions.Thorax, 1994